Evidence map›Paper›PMID 39875771›Full record

ArticleJournal of general internal medicine2025

Readmissions and Mortality After "Before Medically Advised" Hospital Discharges Among Medicare Beneficiaries with Opioid Use Disorder.

Talia S Benheim, Simeon D Kimmel, Miriam George, Patience M Dow

Abstract read
In one paragraph

Article in Journal of general internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Talia S BenheimDepartment of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, USA.ORCID 0000-0003-3250-7503
Simeon D KimmelSection of General Internal Medicine, Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center, Boston, MA, USA.
Miriam GeorgeDepartment of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, USA.
Patience M DowDepartment of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, USA. patience_dow@brown.edu.

Funding

Retention and Re-Engagement in Treatment for Addiction following Serious Injection Related Infections (RETAIN)K23DA054363 · NIDA · BOSTON MEDICAL CENTER · PI KIMMEL, SIMEON · 2021 to 2025
$947k
Skilled Nursing Facility Care and Outcomes After Hospitalizations Involving Opioid Use DisorderR21DA053518 · NIDA · BROWN UNIVERSITY · PI DOW, PATIENCE MOYO · 2022 to 2023
$435k
AHRQ HHS 2T32HS000011-38AHRQ HHS T32 HS000011NIDA NIH HHS 5K23DA054363NIDA NIH HHS K23 DA054363NIDA NIH HHS R21 DA053518NIDA NIH HHS R21DA053518
6 · The paper itself

Abstract

background"Before medically advised" (BMA) discharges are rising among hospitalized people with opioid use disorder (OUD) and associated with worse outcomes. However, little is known about BMA discharge among the growing share of U.S. Medicare beneficiaries with OUD.

objectiveTo examine patterns of hospital readmissions and mortality by discharge type among Medicare beneficiaries with OUD.

designRetrospective cohort study using 100% national inpatient Medicare data from 2016 to 2019.

participantsFee-for-service Medicare beneficiaries age 18 + with an OUD diagnosis during an inpatient hospitalization. Discharge types were classified as BMA, home, skilled nursing facilities (SNFs), or non-SNF institutional settings. MAIN MEASURES: Using linear probability models adjusted for demographic, clinical, and hospital covariates, we examined 30-day unplanned all-cause readmission and mortality probabilities across discharge types. Secondarily, we assessed time until readmission and mortality, repeated readmissions or BMA discharges, readmission to different hospitals, and primary readmission diagnoses. KEY

resultsAmong 339,712 hospitalized Medicare beneficiaries with OUD, 13,997 (4.1%) were discharged BMA. Within 30 days, 25.5% of patients discharged BMA were readmitted and 2.5% died. Compared to other discharges, readmissions after BMA discharge occurred sooner (9.9 vs. 12.8-13.3 days), and were more likely to happen repeatedly (23.4% vs. 13.1-18.3%), end in another BMA discharge (20.9% vs. 0.8-3.5%), and take place at different hospitals (50.8% vs. 29.8-37.6%). Adjusted readmission probabilities for BMA discharges were 7.1 percentage points (pp) higher than home discharges and 6.0-8.9 pp higher than SNF and non-SNF discharges (all p < 0.001). Adjusted mortality probabilities for BMA discharges were 0.7 pp higher than home discharges, but 0.8-1.9 pp lower than SNF and non-SNF discharges (all p < 0.001).

conclusionsBMA discharge among Medicare beneficiaries with OUD is associated with fragmented patterns of post-discharge care, and increased readmissions and deaths relative to home discharges. Efforts are needed to address the drivers and consequences of BMA discharge among individuals with OUD in Medicare.

Indexed as

MedicareOpioid-Related DisordersPatient DischargePatient ReadmissionAgedAged, 80 and overCohort StudiesFemaleHumansMaleMiddle AgedMortalityRetrospective StudiesSkilled Nursing FacilitiesUnited Statesagainst medical advicebefore medically advisedhospital readmissionsMedicareopioid use disorder

Identifiers

PMID39875771
PMCPMC12508336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.